News|Articles|October 31, 2024
WCG Meets Enrollment 24 Months Early for Top 5 Pharma’s Decentralized Trial
Author(s)WCG Clinical
A sponsor needed to get their Phase II dermatology study enrollment back on track. The study was underway for 11 months across 32 sites globally with only 20 subjects enrolled to date. With WCG support, enrollment was concluded 24 months ahead of schedule.
Trending on Applied Clinical Trials Online
1
When the Slack Runs Out: AI and the CRO Operating Model
2
Why Site Payment Inconsistency Has Persisted for So Long
3
Why Payment Performance Has Become a Competitive Differentiator for Sponsors
4
Speed, Discipline, and the New Rules of Biotech Development: Q&A with Stella K. Vnook, PhD, Kaida BioPharma and Aviva Ventures
5